An Interview with Dr. Singh CEO Singh Biotechnology
Evan Donovan, WFLA News, March 12, 2020
Proactive has published the following Singh Biotechnology News.
Singh Biotechnology's low-cost virtual company model advances cancer therapies rapidly.
"Singh Biotechnology CEO Dr Sunanda Singh tells Proactive the Florida-based 'virtual' biotech, who outsources all of its R&D to contract resource companies in the US, is in the late pre-clinical stage with its therapies to treat pancreatic and bone cancer. Singh says…"
Author: Christine Corrado
You will also find this published on:
